Early microglial activation following neonatal excitotoxic brain damage in mice: A potential target for neuroprotection

Neuroscience

Volumn 121, Issue 3, 2003, Pages 619-628

  Dommergues, M A ^a   Plaisant, F ^a   Verney, C ^a   Gressens, P ^a  

^a HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

DAB; Diaminobenzidine; Ibotenate; Macrophage; Minocycline; N methyl D aspartate; NMDA; P; PBS; PCNA; Phosphate buffer saline; Postnatal day; Proliferating cell nuclear antigen; SAP; Saporin

Indexed keywords

BIOLOGICAL MARKER; CASPASE 3; CD45 ANTIGEN; CHLOROQUINE; COLCHICINE; IBOTENIC ACID; LECTIN; MINOCYCLINE; NEUROPROTECTIVE AGENT; SAPORIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CELL ACTIVATION; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVATION; EXCITOTOXICITY; IMMUNOHISTOCHEMISTRY; INJECTION; MICROGLIA; MONOCYTE; MOUSE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ANIMALS; ANIMALS, NEWBORN; ANTI-BACTERIAL AGENTS; ANTIGENS, CD45; ANTIRHEUMATIC AGENTS; BRAIN; BRAIN INJURIES; CELL COUNT; CELL DEATH; CEREBRAL CORTEX; CEREBRAL PALSY; CHLOROQUINE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; GLYCOPROTEINS; IBOTENIC ACID; IMMUNOHISTOCHEMISTRY; LECTINS; LEUKEMIC INFILTRATION; MACROPHAGE-1 ANTIGEN; MICE; MICROGLIA; MINOCYCLINE; NEURONS; NEUROPROTECTIVE AGENTS; PROLIFERATING CELL NUCLEAR ANTIGEN; STAINING AND LABELING; TIME FACTORS;

EID: 1642321822     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(03)00558-X     Document Type: Article

References (30)

1. Arvin K.L., Han B.H., Du Y., Lin S.Z., Paul S.M., Holtzman D.M. Minocycline markedly protects the neonatal brain against hypoxic-ischemic injury. Ann Neurol. 52:2002;54-61.
2. Barron K.D. The microglial cell a historical review. J Neurol Sci. 134:(Suppl):1995;57-68.
3. Chen M., Ona V.O., Li M., Ferrante R.J., Fink K.B., Zhu S., Bian J., Guo L., Farrell L.A., Hersch S.M., Hobbs W., Vonsattel J.P., Cha J.H., Friedlander R.M. Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nat Med. 6:2000;797-801.
4. Dommergues M.A., Patkai J., Renauld J.C., Evrard P., Gressens P. Proinflammatory cytokines and interleukin-9 exacerbate excitotoxic lesions of the newborn murine neopallium. Ann Neurol. 47:2000;54-63.
5. Giordana M.T., Attanasio A., Cavalla P., Migheli A., Vigliani M.C., Schiffer D. Reactive cell proliferation and microglia following injury to the rat brain. Neuropathol Appl Neurobiol. 20:1994;163-174.
6. Giulian D (1988) Immunosuppression as a treatment for acute injury of the central nervous system. In: Current issues in neural regeneration research, Vol. 48 (Liss AR, ed), pp 281-290. New York: WB Saunders.
7. Giulian D., Chen J., Ingeman J.E., George J.K., Noponen M. The role of mononuclear phagocytes in wound healing after traumatic injury to adult mammalian brain. J Neurosci. 9:1989;4416-4429.
8. Giulian D., Robertson C. Inhibition of mononuclear phagocytes reduces ischemic injury in the spinal cord. Ann Neurol. 27:1990;33-42.
9. Gressens P., Marret S., Hill J.M., Brenneman D.E., Gozes I., Fridkin M., Evrard P. Vasoactive intestinal peptide prevents excitotoxic cell death in the murine developing brain. J Clin Invest. 100:1997;390-397.
10. Holmin S., Mathiesen T. Dexamethasone and colchicine reduce inflammation and delayed oedema following experimental brain contusion. Acta Neurochir (Wien). 138:1996;418-424.
11. Husson I., Mesples B., Bac P., Vamecq J., Evrard P., Gressens P. Melatoninergic neuroprotection of the murine periventricular white matter against neonatal excitotoxic challenge. Ann Neurol. 51:2002;82-92.
12. Kanai T., Watanabe M., Okazawa A., Sato T., Yamazaki M., Okamoto S., Ishii H., Totsuka T., Iiyama R., Okamoto R., Ikeda M., Kurimoto M., Takeda K., Akira S., Hibi T. Macrophage-derived IL-18-mediated intestinal inflammation in the murine model of Crohn's disease. Gastroenterology. 121:2001;875-888.
13. Laudenbach V., Calo G., Guerrini R., Lamboley G., Benoist J.F., Evrard P., Gressens P. Nociceptin/orphanin FQ exacerbates excitotoxic white-matter lesions in the murine neonatal brain. J Clin Invest. 107:2001;457-466.
14. Laudenbach V., Medja F., Zoli M., Rossi F.M., Evrard P., Changeux J.P., Gressens P. Selective activation of central subtypes of the nicotinic acetylcholine receptor has opposite effects on neonatal excitotoxic brain injuries. FASEB J. 16:2002;423-425.
15. Marret S., Mukendi R., Gadisseux J.F., Gressens P., Evrard P. Effect of ibotenate on brain development an excitotoxic mouse model of microgyria and posthypoxic-like lesions. J Neuropathol Exp Neurol. 54:1995;358-370.
16. Marty S., Dusart I., Peschanski M. Glial changes following an excitotoxic lesion in the CNS I. Microglia/macrophages. Neuroscience. 45:1991;529-539.
17. McRae A., Gilland E., Bona E., Hagberg H. Microglia activation after neonatal hypoxic-ischemia. Brain Res Dev Brain Res. 84:1995;245-252.
18. Murphy D.J., Sellers S., MacKenzie I.Z., Yudkin P.L., Johnson A.M. Case-control study of antenatal and intrapartum risk factors for cerebral palsy in very preterm singleton babies. Lancet. 346:1995;1449-1454.
19. Nelson K.B., Ellenberg J.H. Antecedents of cerebral palsy multivariate analysis of risk. N Engl J Med. 315:1986;81-86.
20. Pharoah P.O., Cooke T., Cooke R.W., Rosenbloom L. Birthweight specific trends in cerebral palsy. Arch Dis Child. 65:1990;602-606.
21. Piani D., Spranger M., Frei K., Schaffner A., Fontana A. Macrophage-induced cytotoxicity of N-methyl-D-aspartate receptor positive neurons involves excitatory amino acids rather than reactive oxygen intermediates and cytokines. Eur J Immunol. 22:1992;2429-2436.
22. Shapiro L.E., Knowles S.R., Shear N.H. Comparative safety of tetracycline, minocycline, and doxycycline. Arch Dermatol. 133:1997;1224-1230.
23. Tahraoui S.L., Marret S., Bodenant C., Leroux P., Dommergues M.A., Evrard P., Gressens P. Central role of microglia in neonatal excitotoxic lesions of the murine periventricular white matter. Brain Pathol. 11:2001;56-71.
24. Tikka T., Fiebich B.L., Goldsteins G., Keinanen R., Koistinaho J. Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J Neurosci. 21:2001;2580-2588.
25. Trowbridge I.S., Thomas M.L. CD45 an emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development. Annu Rev Immunol. 12:1994;85-116.
26. Volpe J (2001) Neurology of the Newborn. Philadelphia.
27. Wood P.L. Microglia as a unique cellular target in the treatment of stroke potential neurotoxic mediators produced by activated microglia. Neurol Res. 17:1995;242-248.
28. Yrjanheikki J., Keinanen R., Pellikka M., Hokfelt T., Koistinaho J. Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc Natl Acad Sci USA. 95:1998;15769-15774.
29. Yrjanheikki J., Tikka T., Keinanen R., Goldsteins G., Chan P.H., Koistinaho J. A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc Natl Acad Sci USA. 96:1999;13496-13500.
30. Zupan V., Gonzalez P., Lacaze-Masmonteil T., Boithias C., d'Allest A.M., Dehan M., Gabilan J.C. Periventricular leukomalacia risk factors revisited. Dev Med Child Neurol. 38:1996;1061-1067.